Helene Savignac

This inventor holds 13 USPTO granted patents and 12 published patent applications, plus 3 CIPO patents and 8 EPO patents. Top assignees: 4D Pharma Research Limited, 4D Pharma Plc, Cj Bioscience, Inc.. Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helene Savignac. Retrieved from https://idiyas.com/inventor/helene-savignac

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 12)

% Patents Active = 61.5

CIPO Patents = 3 (Patent Applications = 11)

EPO Patents = 8 (Patent Applications = 24)

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 43(Granted Patents)

Location History:

Leeds, GB (2018 - 2021)
Aberdeen, GB (2021 - 2024)

Company Filing History:

7 out of 47

4D Pharma Research Limited

Years Active: 2018-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12048720 - Compositions comprising bacterial strains (2024-07-30),

2. 11779613 - Compositions comprising a bacterial strain of the genusand uses thereof (2023-10-10),

3. 11660319 - Compositions comprising bacterial strains (2023-05-30),

4. 11504405 - Compositions comprising bacterial strains (2022-11-22),

5. 11382936 - Compositions comprising bacterial strains (2022-07-12),

6. 11376284 - Compositions comprising bacterial strains (2022-07-05),

7. 11123379 - Compositions comprising bacterial strains (2021-09-21),

8. 11123378 - Compositions comprising bacterial strains (2021-09-21),

9. 11007233 - Compositions comprising a bacterial strain of the genusand uses thereof (2021-05-18),

10. 10898526 - Compositions comprising bacterial strains (2021-01-26),

11. 10543238 - Compositions comprising bacterial strains (2020-01-28),

12. 10485830 - Compositions comprising bacterial strains (2019-11-26),

13. 10086021 - Compositions comprising bacterial strains (2018-10-02),

Title: Helene Savignac: Innovator in Neurodegenerative Disorder Treatments

Introduction

Helene Savignac is a prominent inventor based in Aberdeen, GB. She has made significant contributions to the field of biotechnology, particularly in the treatment and prevention of neurodegenerative disorders. With a total of 13 patents to her name, her work has garnered attention in both academic and commercial sectors.

Latest Patents

Among her latest patents, Helene has developed compositions comprising bacterial strains aimed at treating and preventing neurodegenerative disorders. These inventions provide innovative solutions that leverage the potential of bacterial strains to address complex health issues.

Career Highlights

Helene has worked with notable companies such as 4D Pharma Research Limited and 4D Pharma Plc. Her experience in these organizations has allowed her to advance her research and contribute to the development of groundbreaking therapies.

Collaborations

Throughout her career, Helene has collaborated with esteemed colleagues, including Imke Elisabeth Mulder and Anna Ettorre. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Helene Savignac's work in the field of neurodegenerative disorders exemplifies the power of innovation in biotechnology. Her contributions continue to pave the way for new treatments that could significantly improve patient outcomes.

Profile summary based on public USPTO records.